INVESTMENTS (Tables)

9 Months Ended

Sep. 30, 2025

Investments, All Other Investments [Abstract]

Schedule of Cash and Financial Assets Measured at Fair Value on a Recurring Basis

The following tables present the Company’s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):

	September 30, 2025
	Cost		Unrealized Gains		Accrued Interest		Estimated Fair Value		Cash & Cash Equivalents		Investment Securities
Cash and cash equivalents, excluding money market accounts	$	82,584	$	—	$	—	$	82,584	$	82,584	$	—
Level 1:
Money market accounts	16,942		—		—		16,942		16,942		—
Government & agency securities	32,095		115		77		32,287		—		32,287
	49,037		115		77		49,229		16,942		32,287
Level 2:
Corporate bonds	41,191		179		329		41,699		—		41,699
Total	$	172,812	$	294	$	406	$	173,512	$	99,526	$	73,986

	December 31, 2024
	Cost		Unrealized Gains (Losses)		Accrued Interest		Estimated Fair Value		Cash & Cash Equivalents		Investment Securities
Cash and cash equivalents, excluding money market accounts	$	77,551	$	—	$	—	$	77,551	$	77,551	$	—
Level 1:
Money market accounts	13,377		—		—		13,377		13,377		—
Government & agency securities	28,920		15		96		29,031		—		29,031
Equity securities	10,000		(3,939)		—		6,061		—		6,061
	52,297		(3,924)		96		48,469		13,377		35,092
Level 2:
Corporate bonds	35,771		227		326		36,324		—		36,324
Total	$	165,619	$	(3,697)	$	422	$	162,344	$	90,928	$	71,416

Schedule of Investment Losses

The

gains and losses related to the Company’s LifeMD investment for the three and nine months ended September 30, 2025 and 2024 are summarized in the table below (in thousands):

	Three months ended September 30,
	2025		2024
Net losses recognized during the period on equity securities	$	—	$	(1,984)
Less: Net losses recognized on equity securities sold	—		—
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date	$	—	$	(1,984)

	Nine months ended September 30,
	2025		2024
Net gains (losses) recognized during the period on equity securities	$	3,222	$	(3,734)
Less: Net gains recognized on equity securities sold	3,222		—
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date	$	—	$	(3,734)